Quarterly Result30 May 2026, 07:03 pm
Biofil Chemicals Approves Audited FY26 Financial Results
AI Summary
Biofil Chemicals & Pharmaceuticals Ltd's Board of Directors approved the audited financial results for the fourth quarter and financial year ended March 31, 2026, along with the audit report, statement of assets and liabilities, and cash flow statement. The board also declared an unmodified opinion of the auditors on the annual audited financial results. The results will be submitted in XBRL mode and uploaded on the company's website and stock exchange websites. Publication of key details with a QR code will be made in Hindi and English newspapers.
Key Highlights
- Audited financial results for Q4 and FY26 approved by the board.
- Auditors' unmodified opinion declared on FY26 audited results.
- Results to be submitted in XBRL mode within the prescribed time.
- Financial results will be available on the company and stock exchange websites.
- Key financial details to be published in newspapers with a QR code.
Price Impact
More from BIOFILCHEM